Next |
home / stock / tpst / tpst message board
Subject | By | Source | When |
---|---|---|---|
There is life out there. Don't give up!!!! Never, | Gator44 | investorshub | 05/01/2023 7:11:13 AM |
$TPST MomentumIts now | tw0122 | investorshub | 04/29/2023 10:34:11 PM |
For sure ..Tempest Announces Positive Early Results from | tw0122 | investorshub | 04/28/2023 1:21:42 PM |
News | Awl416 | investorshub | 04/28/2023 1:08:05 PM |
great news | tw0122 | investorshub | 04/25/2023 11:43:30 PM |
$TPST what do you make of this data? | Awl416 | investorshub | 04/24/2023 1:58:28 AM |
great article | Gator44 | investorshub | 04/21/2023 9:29:46 PM |
bulls and bears | tw0122 | investorshub | 04/19/2023 11:20:07 PM |
$TPST great article | missile_systems | investorshub | 04/17/2023 8:42:36 PM |
$TPST Price now last up | missile_systems | investorshub | 04/17/2023 3:36:22 PM |
$TPST MomentumIts trading up | Awl416 | investorshub | 04/16/2023 4:13:44 PM |
$TPST MomentumIts trading | missile_systems | investorshub | 04/13/2023 9:14:28 AM |
What do you make of this? | Awl416 | investorshub | 04/11/2023 8:09:18 PM |
Price gaining last up | Awl416 | investorshub | 04/11/2023 9:53:32 AM |
$TPST must see | tw0122 | investorshub | 04/11/2023 8:54:15 AM |
$TPST The trading up | missile_systems | investorshub | 04/08/2023 2:03:44 PM |
good read | Awl416 | investorshub | 04/06/2023 2:08:12 PM |
short squeeze signal | missile_systems | investorshub | 04/05/2023 8:26:01 PM |
$TPST MomentumIts gaining last trade up | Awl416 | investorshub | 04/04/2023 10:45:18 PM |
Hello ? | missile_systems | investorshub | 04/28/2022 6:44:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Tempest Therapeutics Inc. Company Name:
TPST Stock Symbol:
NASDAQ Market:
Advancing TPST-1120 into a pivotal Phase 3 trial in first-line HCC and TPST-1495 into a Phase 2 in FAP Reported new preclinical data for TPST-1120 in kidney cancer at the AACR Annual Meeting Published positive data from the Phase 1 Trial of TPST-1120 in patients with advanced soli...
BRISBANE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that collaborators at the Beth Israel Deaconess Medical...
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...